SUMMARY Forty-eight eyes with closed-angle glaucoma and 31 eyes at risk were subjected to corticosteroid provocative tests. 65% and 9-7% respectively responded with a change in pressure .6 mmHg. The responses of the 2 groups were compared with each other and also.with the corticosteroid pressure response in normal eyes. The differences in behaviour between the eyes with closed-angle glaucoma and eyes at risk, and the eyes with closed-angle glaucoma and normal eyes, are statistically highly significant. The implications of.this are discussed. The prevalence of corticosteroid-induced ocular hypertension in closed-angle glaucoma is higher than previously reported.
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Corticosteroid-induced ocular hypertension is a well recognised entity which has been demonstrated and reported by several observers in patients with primary open-angle glaucoma, their siblings and children, and in glaucoma suspects and apparently normal individuals. '-11 There are few published data on the corticosteroid response of patients with closed-angle glaucoma. 214 This study investigates the prevalence of corticosteroid pressure response in 2 groups of eyes related to closed-angle glaucoma.
Materia and
Two groups of eyes were subjected to corticosteroid provocative testing.
Group A consisted of 48 eyes that had sustained closed-angle glaucoma and had been treated by peripheral iridectomy at least 6 months before the beginning of the study. The types of closed-angle glaucoma sustained were classified into chronic, acute, and intermittent.
Six out of the 48 eyes required antiglaucoma therapy to control the intraocular pressure, and the pressures had been well controlled with the same treatment (drops only) for at least 6 months without any change. The antiglaucoma therapy was continued without 'change throughout the corticosteroid provocative test.
Correspondence to Mr A. 0. Akingbehin, FRCS. Group B consisted of 31 eyes at risk of developing closed-angle glaucoma (because the fellow eyes had had a spontaneous episode of closed-angle glaucoma). These eyes were admitted into the study only if they satisfied the following criteria: (1) prophylactic peripheral iridectomy performed with an uneventful postoperative period at least 6 months prior to start of study; (2) contralateral eye had a spontaneous episode of closed-angle glaucoma; (3) open angles as assessed by a slit beam and also gonioscopically; (4) no peripheral anterior synechiae; (5) no pseudoexfoliation of the lens capsule; (6) no significant amount of pigment in angles; (7) normal discs; (8) normal visual fields-central and peripheral; (9) intraocular pressure by applanation, outflow facility, and Po/c ratio all within normal limits; (10) patient not on oral hypotensive agent, namely, acetazolamide.
CORTICOSTEROID PROVOCATIVE TEST
This was performed as follows.
1. Patient education: (a) risks of test; (b) importance of 100% compliance. Patientswere asked to keep a record ofmissed drops. Those who missed 24 out ofa total of 168 administrations over a 6-week period (equivalent to missing one day's administration/week) were judged to have complied poorly, and the test therefore to be invalidated if negative.
2. Pretest detalhed examination of the eye for best visual acuity, herpetic comeal disease, pupillary 6 Abbreviations as in Table 2 .
classified into chronic, acute, and intermittent. Of the 48 eyes provoked 1 had chronic closed-angle glaucoma, 37 acute closed-angle glaucoma, and 10 intermittent closed-angle glaucoma. The number of positive corticosteroid provocative tests in each of these classes was 1, 22, and 8 respectively. The mean change in C value for each of the 3 classes of closed-angle glaucoma was -0-04. When this was considered in relation to the pretest C value, it represented a reduction in outflow facility of 25% for the eyes with chronic closed-angle glaucoma, 19% for the eyes with acute closed-angle glaucoma, and 26-2% for the eyes with intermittent closed-angle glaucoma.
The overall mean AP for the 48 eyes was +8-44 mmHg, and this was accompanied by an overall mean change in outflow facility (AC) of -0-04, a reduction equivalent to 21%.
These results are summarised in Table 4 The data on outflow facility are subjected to parametric statistics because there is no reason to presume that the corticosteroid-induced change in their value is in any way genetically influenced, although it has been suggested that outflow facility is genetically determined. 6 The statistical analysis of the data from this study and the testing of the hypotheses formulated as a logical consequence of the results are summarised in Table 6 .
Discussion
The prevalence of corticosteroid-induced ocular hypertension in eyes with closed-angle glaucoma is much higher than has been previously reported. 65% of the 48 eyes with closed-angle glaucoma in this study had a positive corticosteroid provocative test, and this figure approaches the percentage of responders in primary open-angle glaucoma as cited response in 10 patients with primary open-angle glaucoma is excluded because antiglaucoma therapy was discontinued 7-14 days before the corticosteroid provocative test, and the pressure change in these eyes must therefore be subject to doubt as to whether it was induced entirely by the topical corticosteroids.
The common factor to the 3 groups of eyes with closed-angle glaucoma is an angle-closing mechanism (partial angle closure). Because the presentation of acute closed-angle glaucoma is dramatic, the opportunity for further episodes of angle closure is terminated early by performing a peripheral iridectomy. It is not unreasonable to assume that patients in the other 2 groups-chronic and intermittent-will have had a prolonged episode or several episodes of partial angle closure before the diagnosis was made, because of the less dramatic mode of presentation. The inference from this is that there is a positive correlation between the episodes of partial angle closure and corticosteroid pressure response (see Table 4 ).
The importance of partial angle closure was given prominence by Mapstone'7"l9 when he wrote, 'Acute closed-angle glaucoma is merely an incident (but an obvious one) in the evolution of a disease process that can have other more subtle consequences too. ' Table 7 . There is a highly significant difference (p<001) in the distribution of corticosteroid pressure response as shown in Table 6 , no. 6, and this can be attributed to the closed-angle glaucoma. The alternative explanation is that both closed-angle glaucoma and corticosteroid pressure response could be due to a third common factor. The corticosteroid pressure response in the 31 eyes at risk is in close agreement with Kitazawa's result in 10 patients, and the percentage of responders is similar to that reported for normal eyes by some -observers. 6 Comparing this with the response in closed-angle eyes in this study (see Table 6 , row 5) we find a highly significant difference (p<O0001).
From these comparisons it becomes apparent that eyes with closed-angle glaucoma behave differently from normal eyes and eyes at risk in their pressure response to topical corticosteroids. Because of the nature of the samples used in testing this hypothesis, the genetic influence on the high prevalence of corticosteroid-induced ocular hypertension in eyes with closed-angle glaucoma (65%), and on the highly significant difference in response when compared with normal eyes and eyes at risk, cannot be properly assessed and eliminated. Yet because of the clinical significance of this hypothesis it is important that the genetic influence be eliminated. This can be done simply by using matched pairs of eyes which are provided by patients with unilateral closed-angle glaucoma. Any difference between the paired eyes would be a reflection of the effect of the closed-angle glaucoma and not of the genetic composition of the patient, as this will be common to both eyes. This is the subject of the second part of this paper. Armaly2 used this experimental model in 1967 but with respect to traumatic angle recession glaucoma in 11 patients. He concluded that the response to topical dexamethasone did not reflect the local changes in the glaucomatous eye but the genotype of the patient.
The following conclusions are drawn: (1) The prevalence of corticosteroid-induced ocular hypertension in closed-angle glaucoma eyes is higher than previously reported. (2) Eyes at risk of developing closed-angle glaucoma (because the fellow eyes had spontaneous closed-angle glaucoma) have a much lower prevalence of positive corticosteroid pressure response. (3) There is a marked difference between the corticosteroid pressure response of eyes with closed-angle glaucoma and normal eyes or eyes at risk.
